Clinical study ยท Skin and Cancer Foundation Inc. ยท 2026

17.4% more hair on average in 6 months.

We tested the actual products, not just their ingredients. We gave the HairSmart Protocol to 30 men and women with pattern hair loss, and dermatologists measured every scalp for 6 months.

Men & women 100% drug-free ยท botanical Hair count gain statistically significant
30 of 30
Increased hair count
100% of participants
+23.98%
Average TVR change
Group-average change not statistically significant (p=.626)
52%
Better quality of life
DLQI ยท p<.001
0
Side effects reported
Across all 30 participants

Individual results vary.

Results at 6 months

The numbers, no spin.

Women n=16
+17.8%avg. hair count change ยท p<.001
Baseline335.1 hairs/cmยฒ
6 months386.6 hairs/cmยฒ (+51.5)
+21.0%frontal hair count (p<.001)
+31.74%average TVR change
Men n=14
+16.9%avg. hair count change ยท p<.001
Baseline364.1 hairs/cmยฒ
6 months421.6 hairs/cmยฒ (+57.5)
+16.1%frontal hair count (p<.001)
+15.12%average TVR change

Change from baseline at 6 months

Hair count and TVR rose for all participants, women and men.

Hair count

Change in hairs per cmยฒ, p<.001 for all three

+17.38%
+17.80%
+16.90%
Totaln=30
Womenn=16
Menn=14

TVR

Terminal-to-vellus hair ratio, average change

+23.98%
+31.74%
+15.12%
Totaln=30
Womenn=16
Menn=14

Source: statistical analysis by the Department of Dermatology, Skin and Cancer Foundation Inc. Hair count by TrichoScan, Wilcoxon signed-rank test. Hair count and TVR percentages are the average of each participant's individual percentage change. Individual results vary.

Disclosure: study commissioned by HairSmart; statistical analysis by the Department of Dermatology, Skin and Cancer Foundation Inc. (Beltejar & Mulato, 2026). Open-label study with no placebo group. Photos used with written consent.

TrichoScan before & after

Real participants. Real results.

Case 1 of 8 ยท MNF2

Woman, 50

+19.05%hair count

Patient IDs match the full study report. Individual results vary.

Quality of life

Hair loss bothered them half as much

After 6 months, participants said hair loss affected their confidence, social life and daily routine far less.

52%

improvement in quality of lifeAll participants ยท p<.001

62%

improvement ยท women

p<.001
34%

improvement ยท men

p=.098 ยท not statistically significant
44%

of women said hair loss no longer affected their daily life, up from 0%

Measured with the Dermatology Life Quality Index (DLQI), a standard 10-question survey on how a scalp or skin condition affects daily life. Average scores fell from 9.2 to 4.4 (lower is better).

The protocol studied

What participants took daily

The exact products you can buy. Participants took the same formulas we sell, not special research versions. Our supplements contain no fillers, flow agents or gelatin, dairy, wheat and soy.

Women's protocol

HairSmart Protect DHT Blocker bottle

Protect DHT Blocker

Saw palmetto, stinging nettle, pygeum bark, pumpkin seed and green tea extracts.

HairSmart H5 Growth+ Hair Vitamin bottle with capsules

H5 Growth+ Hair Vitamin

8 Ayurvedic botanicals (Bhringraj, Brahmi, Amla, Ashwagandha, Turmeric, Fenugreek, Neem, Nettle root), 5,000 mcg biotin, amino acids, vitamins and minerals.

HairSmart Growth Accelerator Serum spray bottle

Growth Accelerator Serum

Topical serum with Anantmool, Amla, Neem, onion bulb extract, hydrolyzed keratin and amino acids.

Shop the women's protocol

Men's protocol

HairSmart Protect DHT Blocker bottle

Protect DHT Blocker

Saw palmetto, stinging nettle, pygeum bark, pumpkin seed and green tea extracts.

HairSmart H5 Growth+ Hair Vitamin bottle with capsules

H5 Growth+ Hair Vitamin

8 Ayurvedic botanicals (Bhringraj, Brahmi, Amla, Ashwagandha, Turmeric, Fenugreek, Neem, Nettle root), 5,000 mcg biotin, amino acids, vitamins and minerals.

Shop the men's protocol

How the study worked

We counted hairs, not opinions

Design
Open-label, single-group, before-and-after study
Duration
6 months, daily use; visits at baseline, 3 and 6 months
Condition studied
Androgenetic alopecia (male and female pattern hair loss)
Participants
30 adults: 16 women, 14 men, ages 29โ€“74
Hair loss grade
Norwood IIโ€“VI (men), Ludwig Iโ€“III (women)
Sites
Minnesota, USA (7) and the Philippines (23)
Measures
Hair count per cmยฒ and terminal-to-vellus ratio by TrichoScan/ Hair metrics, in the same marked scalp zones at every visit, with no needles or biopsies; quality of life by DLQI
Statistics
Wilcoxon signed-rank test, two-sided, ฮฑ=0.05

The doctors behind the study

Dr. Ronald Shapiro, MD

Dr. Ronald Shapiro, MD

Investigator, Minnesota site

Medical Director, Hair Transplant Specialists. ABHRS Diplomate.ProfileLinkedIn
Dr. Mariel Arambulo, MD, FPDS

Dr. Mariel Arambulo, MD, FPDS

Investigator, Philippines site

Dermatologist, Asian Hair Restoration Center.LinkedIn
Dr. Bea Mergie T. Beltejar, MD

Dr. Bea Mergie T. Beltejar, MD

Statistical analysis & report, Dept. of Dermatology, Skin and Cancer Foundation Inc.

Dermatology Resident, Skin and Cancer Foundation Inc.
Dr. Penelope V. Mulato, MD

Dr. Penelope V. Mulato, MD

Statistical analysis & report, Dept. of Dermatology, Skin and Cancer Foundation Inc.

Dermatology Resident, Skin and Cancer Foundation Inc.

Safety record

0 side effects reported in 6 months

Across all 30 participants, men and women. No scalp irritation, allergic reactions or medication interactions.

Physician-monitored

Every participant was examined by a doctor at baseline, 3 months and 6 months.

Drug-free

A botanically derived regimen, with no prescription drugs.

Check with your doctor first

Especially if you are pregnant or nursing, take medication, or manage a medical condition.

What's next: the study is being prepared for publication, and a larger controlled study is planned.

Questions about the study

No. Most brands rely on published research on individual ingredients. We tested our actual products, on real people with pattern hair loss, measured by dermatologists.

Clinically studied. Ready to use at home.

Beltejar & Mulato (2026). Includes methods, results by sex, scalp region and grade, participant-level data, before/after images and the full safety log. Providers: request the statistical appendix.